Eurofarma

Eurofarma

Innovative pharmaceutical solutions enhancing health accessibility and quality of life. Learn more
  • Edit
DateInvestorsAmountRound
*

$150m

Debt
*

BRL1.0b

Debt
*

BRL500m

Debt
*
N/A

BRL3.0b

Debt
Total Funding-

Recent News about Eurofarma

Edit
More about Eurofarmainfo icon
Edit

Eurofarma is a leading pharmaceutical company focused on making healthcare accessible and improving the quality of life for people. Operating primarily in the Latin American market, Eurofarma serves a diverse range of clients including hospitals, clinics, and individual consumers. The company’s business model revolves around the development, production, and distribution of a wide array of pharmaceutical products, from prescription medications to over-the-counter drugs. Revenue is generated through the sale of these products, as well as through partnerships and licensing agreements. Eurofarma is also deeply committed to social responsibility, with initiatives in environmental sustainability, education, and community health. Key projects include the Eurofarma Institute, which has provided over 77,000 consultations in areas such as complementary, environmental, and youth education. The company’s efforts in sustainability are highlighted by programs like the Sustainable Development Primer and initiatives to decontaminate medicine packaging at home. Eurofarma’s commitment to social causes is further exemplified by its Lactare project, encouraging breast milk donation to support infant health.

Keywords: pharmaceutical, healthcare, Latin America, prescription medications, over-the-counter drugs, sustainability, education, community health, partnerships, licensing.

Investments by Eurofarma

Edit
Medimetriks Pharmaceuticals
ACQUISITION by Eurofarma Nov 2022
Genfar
ACQUISITION by Eurofarma Mar 2023